Video Interview with Massimo Radaelli
John E. Kaye
- Published
- Videos
Noventia Pharma is a speciality pharmaceutical Company based in Milano, Italy. Founded in 2009 and with operations in Southern Europe, Noventia’s focus is the research, development, and marketing of Orphan Drugs.
Massimo Radaelli is the Founder, President and CEO of Noventia Pharma, and also the CEO and Board Member of Napo Therapeutics. Both companies have Rare Diseases as their primary focus.
TOP STORIES
-
Infront hires Deutsche Börse data expert Jeff Caldwell as AI transforms financial markets -
US rocket firm plans Scottish launches in bid to revive failed Highland spaceport -
Job adverts must reveal salaries under new ‘say what you pay’ law -
Ireland's most wanted jobs for 2027 revealed as employers offer higher salaries to attract talent -
American firms sign landmark deal to beam solar power from space as Europe faces AI energy crunch -
Europe’s winners and losers as Democrats seize Congress in crushing blow to Trump -
Spanish developer CLERHP reports US$410m in Caribbean property sales as profits return -
Britain launches first major study into ‘forever chemicals’ lurking in our bodies -
Scientists close in on mysterious ‘zeptoverse’ after 40-year hunt for ultra-rare particle -
Cambodia offers free sightseeing tours to stranded Villa Vie Odyssey passengers -
Bahrain lands $3.9bn investment deal with DHL, AirAsia and hotel giant Meliá -
Binance customers pull $3.6bn from crypto giant after record-breaking heist -
European bosses pocket 12 per cent pay rise as earnings gap with workers widens -
Businesses buying AI faster than they can make it pay, Manchester research finds -
Millions face ID and facial scans to use social media under UK age ban -
Denmark moves to ban ‘frankenchickens’ as UK faces calls to follow suit -
Jaguar Land Rover cyberattack was state-sponsored, former UK minister claims -
AI could 'help pharmaceutical companies spot clinical trial problems before they escalate' -
Raining cats and dogs? Brits have 17 ways to describe a downpour – and some are downright bizarre -
Rare jewellery returns to Japan after 50 years as German museum lends historic treasures to Kyoto -
Dan Brown drops tantalising hint about where his next thriller could be set -
Anthropic warns AI could pose ‘existential risks’ as it files for stock market flotation -
North Korean agents are infiltrating Western businesses by posing as employees, security chief warns -
Route 66 turns 100 next month – and there’s never been a better excuse for Europeans to hit the road -
Serbia erupts in celebration as student protesters end Vučić’s 14-year grip on power
Video Interview with Massimo Radaelli
John E. Kaye
- Published
- Videos
Noventia Pharma is a speciality pharmaceutical Company based in Milano, Italy. Founded in 2009 and with operations in Southern Europe, Noventia’s focus is the research, development, and marketing of Orphan Drugs.
Massimo Radaelli is the Founder, President and CEO of Noventia Pharma, and also the CEO and Board Member of Napo Therapeutics. Both companies have Rare Diseases as their primary focus.
TOP STORIES
-
Infront hires Deutsche Börse data expert Jeff Caldwell as AI transforms financial markets -
US rocket firm plans Scottish launches in bid to revive failed Highland spaceport -
Job adverts must reveal salaries under new ‘say what you pay’ law -
Ireland's most wanted jobs for 2027 revealed as employers offer higher salaries to attract talent -
American firms sign landmark deal to beam solar power from space as Europe faces AI energy crunch -
Europe’s winners and losers as Democrats seize Congress in crushing blow to Trump -
Spanish developer CLERHP reports US$410m in Caribbean property sales as profits return -
Britain launches first major study into ‘forever chemicals’ lurking in our bodies -
Scientists close in on mysterious ‘zeptoverse’ after 40-year hunt for ultra-rare particle -
Cambodia offers free sightseeing tours to stranded Villa Vie Odyssey passengers -
Bahrain lands $3.9bn investment deal with DHL, AirAsia and hotel giant Meliá -
Binance customers pull $3.6bn from crypto giant after record-breaking heist -
European bosses pocket 12 per cent pay rise as earnings gap with workers widens -
Businesses buying AI faster than they can make it pay, Manchester research finds -
Millions face ID and facial scans to use social media under UK age ban -
Denmark moves to ban ‘frankenchickens’ as UK faces calls to follow suit -
Jaguar Land Rover cyberattack was state-sponsored, former UK minister claims -
AI could 'help pharmaceutical companies spot clinical trial problems before they escalate' -
Raining cats and dogs? Brits have 17 ways to describe a downpour – and some are downright bizarre -
Rare jewellery returns to Japan after 50 years as German museum lends historic treasures to Kyoto -
Dan Brown drops tantalising hint about where his next thriller could be set -
Anthropic warns AI could pose ‘existential risks’ as it files for stock market flotation -
North Korean agents are infiltrating Western businesses by posing as employees, security chief warns -
Route 66 turns 100 next month – and there’s never been a better excuse for Europeans to hit the road -
Serbia erupts in celebration as student protesters end Vučić’s 14-year grip on power



























